Principal Financial Group’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$56.1M Sell
700,159
-121,666
-15% -$10M 0.03% 451
2025
Q4
$70.1M Buy
821,825
+16,583
+2% +$1.36M 0.04% 367
2025
Q3
$62.6M Sell
805,242
-4,345
-0.5% -$339K 0.03% 402
2025
Q2
$63.3M Sell
809,587
-9,499
-1% -$708K 0.03% 393
2025
Q1
$59.4M Buy
819,086
+25,161
+3% +$1.8M 0.03% 414
2024
Q4
$58.8M Sell
793,925
-23,591
-3% -$1.65M 0.03% 421
2024
Q3
$53.9M Buy
817,516
+17,647
+2% +$1.28M 0.03% 447
2024
Q2
$73.9M Sell
799,869
-8,507
-1% -$753K 0.04% 340
2024
Q1
$77.2M Sell
808,376
-11,461
-1% -$963K 0.05% 340
2023
Q4
$62.5M Sell
819,837
-12,712
-2% -$885K 0.04% 372
2023
Q3
$57.7M Sell
832,549
-144,021
-15% -$11.6M 0.04% 366
2023
Q2
$92.1M Buy
976,570
+37,963
+4% +$3.3M 0.06% 261
2023
Q1
$77.7M Sell
938,607
-37,292
-4% -$2.93M 0.06% 295
2022
Q4
$72.8M Sell
975,899
-69,725
-7% -$5.37M 0.05% 296
2022
Q3
$86.4M Buy
1,045,624
+9,442
+0.9% +$909K 0.07% 242
2022
Q2
$98.5M Buy
1,036,182
+48,594
+5% +$5.03M 0.07% 230
2022
Q1
$116M Buy
987,588
+45,181
+5% +$5.07M 0.07% 234
2021
Q4
$122M Sell
942,407
-28,341
-3% -$3.31M 0.07% 230
2021
Q3
$110M Buy
970,748
+30,864
+3% +$3.52M 0.07% 241
2021
Q2
$97.3M Sell
939,884
-5,705
-0.6% -$538K 0.06% 262
2021
Q1
$79.1M Sell
945,589
-73,748
-7% -$6.23M 0.06% 297
2020
Q4
$93M Sell
1,019,337
-96,855
-9% -$8.03M 0.07% 263
2020
Q3
$89.1M Sell
1,116,192
-44,267
-4% -$3.45M 0.08% 248
2020
Q2
$80.2M Buy
1,160,459
+88,568
+8% +$6.29M 0.07% 276
2020
Q1
$67.4M Sell
1,071,891
-45,099
-4% -$3.25M 0.07% 273
2019
Q4
$86.9M Sell
1,116,990
-11,979
-1% -$935K 0.07% 294
2019
Q3
$82.8M Buy
1,128,969
+342
+0% +$24K 0.07% 287
2019
Q2
$69.5M Sell
1,128,627
-138,228
-11% -$8.36M 0.06% 315
2019
Q1
$80.8M Sell
1,266,855
-108,381
-8% -$6.19M 0.08% 285
2018
Q4
$70.2M Buy
1,375,236
+27,051
+2% +$1.37M 0.07% 288
2018
Q3
$78.2M Buy
1,348,185
+20,964
+2% +$1.03M 0.07% 302
2018
Q2
$64.4M Sell
1,327,221
-57,741
-4% -$2.7M 0.06% 338
2018
Q1
$64.4M Buy
1,384,962
+70,956
+5% +$3.08M 0.06% 346
2017
Q4
$49.4M Sell
1,314,006
-81,075
-6% -$2.98M 0.05% 420
2017
Q3
$50.8M Sell
1,395,081
-2,574
-0.2% -$98.2K 0.05% 409
2017
Q2
$55.1M Buy
1,397,655
+412,929
+42% +$15.1M 0.06% 390
2017
Q1
$30.9M Sell
984,726
-8,337
-0.8% -$261K 0.04% 498
2016
Q4
$31M Sell
993,063
-28,923
-3% -$937K 0.04% 483
2016
Q3
$41.1M Sell
1,021,986
-81,114
-7% -$3.05M 0.05% 354
2016
Q2
$36.7M Buy
1,103,100
+18,231
+2% +$624K 0.05% 347
2016
Q1
$31.9M Buy
1,084,869
+18,126
+2% +$500K 0.05% 381
2015
Q4
$28.1M Buy
1,066,743
+65,235
+7% +$1.69M 0.04% 422
2015
Q3
$23.7M Buy
1,001,508
+42,372
+4% +$1.02M 0.04% 471
2015
Q2
$22.8M Buy
959,136
+23,190
+2% +$523K 0.03% 523
2015
Q1
$22.2M Sell
935,946
-17,004
-2% -$381K 0.03% 497
2014
Q4
$20.2M Sell
952,950
-252
-0% -$5.06K 0.03% 534
2014
Q3
$16.2M Buy
953,202
+52,794
+6% +$833K 0.03% 619
2014
Q2
$12.9M Buy
900,408
+152,772
+20% +$2.07M 0.02% 763
2014
Q1
$9.24M Sell
747,636
-186,300
-20% -$2.15M 0.02% 962
2013
Q4
$10.2M Buy
933,936
+164,442
+21% +$1.85M 0.02% 875
2013
Q3
$8.93M Sell
769,494
-203,922
-21% -$2.39M 0.02% 879
2013
Q2
$10.9M Buy
+973,416
New +$11.5M 0.02% 709

Other funds holding EW

Principal Financial Group's EW Position: Q1 2026 in Review

Principal Financial Group reduced its Edwards Lifesciences (EW) stake by 15% in Q1 2026, selling an estimated $10M and leaving 700,159 shares worth $56.1M. The position accounts for 0.03% of the portfolio, ranked #451.

Principal Financial Group first reported a position in EW in Q2 2013 and has held it in 52 quarters since. The position peaked at $122M in Q4 2021. 1,284 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Principal Financial Group held 700,159 shares of Edwards Lifesciences worth $56.1M as of Q1 2026.
  • Principal Financial Group sold 121,666 Edwards Lifesciences shares in Q1 2026, an estimated $10M.
  • Edwards Lifesciences made up 0.03% of Principal Financial Group's portfolio in Q1 2026, its #451 holding.
  • Principal Financial Group first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 52 quarters since.
  • Principal Financial Group's Edwards Lifesciences position peaked at $122M in Q4 2021.
  • 1,284 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Principal Financial Group's 13F filing for Q1 2026, filed 4 May 2026.